Status:
COMPLETED
Consultation to Announce the End of Chemotherapy and Specific Treatments in an Outpatient Setting: Evaluation of the Psychological Impact and Information Exchange.
Lead Sponsor:
Institut Curie
Conditions:
Cancer
Eligibility:
All Genders
18-125 years
Brief Summary
The average 5-year survival rate for patients diagnosed with cancer in France is estimated at 53%. Nearly half of all patients diagnosed with cancer are not alive 5 years after diagnosis Discontinuati...
Detailed Description
In this pilot study, we will describe for the first time the discontinuation of anti-tumour treatments in outpatients with advanced cancer and evaluate the psychological impact on patients following t...
Eligibility Criteria
Inclusion
- Major outpatients with advanced cancer for whom anti-tumour treatment is announced by the oncologist in a conventional oncology consultation or in Palliative Care Day Hospital.
- Patient who speaks and understands the French language.
- Patient over 18 years of age.
- Patient informed and not opposed.
Exclusion
- Refusal of the patient or doctor to participate in the study.
- Patient does not speak or understand the French language.
- Patient under 18 years of age.
- Persons deprived of liberty or under guardianship (including curatorship).
- Persons of legal age under court protection.
- Inability to participate in the study for geographical, social or psychological psychological reasons.
Key Trial Info
Start Date :
January 27 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 25 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05293925
Start Date
January 27 2022
End Date
July 25 2023
Last Update
December 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Curie
Paris, France, 75005